LYPLA1 and diabetes mellitus: Our results demonstrate for the first time that LPLI has potent protective effects against inflammation and apoptosis in diabetes-induced SMGs via its suppression of HMGB1/AGE/RAGE, which in turn inhibits the NF-κB pathway.